Photo of Dr Tommy Rampling

Dr Tommy Rampling

Email:

Location:

  • University College Hospital
  • Hospital for Tropical Diseases

GMC/GDC number:

6079625

Professional background

Tommy is a consultant in infectious diseases and clinical virology and holds joint positions at the Hospital for Tropical Diseases at University College London Hospitals, and the Rare and Imported Pathogens Laboratory (RIPL), at the UK Health Security Agency (UKHSA) where he is part of the team delivering the national Imported Fever Service. He has an interest in emerging infectious diseases and severe viral infections. Through his work at RIPL Tommy contributes to the national response to severe infectious threats such as Ebola, Marburg and Monkeypox.

Specialties

Research interests

Tommy is an honorary Associate Professor at UCL and has led clinical trials evaluating novel vaccines for infections including malaria and Ebola with the Jenner Institute in Oxford. More recently he has been a principal and senior co-investigator for multiple trials of vaccines and therapeutics for COVID-19.

Publications

  • COVID-19 associated hyperinflammation (COV-HI) and escalation of patient care: a retrospective longitudinal cohort study
    Manson J, Crooks C, Naja M, Ledlie A, Goulden B, Liddle T, Khan E, Martin- Gutierrez L, Waddington KE, Robinson GA, Ribeiro Santos L, McLoughlin E, Snell A, Adeney C, Schim Van Der Loeff I, Baker KF, Duncan CJA, Hanrath AT, Lendrem C, De Soyza A, Peng J, J'Bari H, Greenwood M, Hawkins E, Peckham H, Mehta P, Marks M, Rampling T, Luintel A, Williams B, Brown M, Singer M, West J, Jury EC, Collin M, Tattersall R. 
    Lancet Rheumatology 2000 https://doi.org/10.1016/ S2665-9913(20)30275-7  Paper 

  • Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate Zain Chaudhry, Marianne Shawe-Taylor, Tommy Rampling, Tim Cutfield, Gabriella Bidwell, Xin Hui S. Chan, Anna Last, Bryan Williams, Sarah Logan, Michael Marks, Hanif Esmail 
    DOI:https://doi.org/10.1016/j.jinf.2021.03.002 Abstract Paper 
     
  • Utilising recruitment and registry data from England to inform the design of future experimental medicine studies for COVID-19. 
    Cunniffe N, Gunter S, Brown M, Burge S, Coyle C, De-Soyza A, Dymond AA, Esmail H, Francis D, Galloway J, Galloway J, Gkrania-Klotsas E, Greenaway J, Katritsis G, Kanagaratnam P, Knolle M, Leonard K, McIntyre Z, Prudon B, Rampling T, Torok E, Warne B, Yates M, Matheson N, Su L, Villar S, Stewar G, Toshner M. BMJ Open 2020 Oct 5;10(10):e044566.
     

  • Parasitic infections of the lung. 
    Rampling T, Garcia Mingo A, Brown M.  Encyclopedia of Respiratory Medicine 2E. [2020 in press] 

  • Clinical and economic impact of implementing OVIVA criteria on patients with bone and joint infections in OPAT 
    Michael Marks, Lucy C K Bell, Imogen Jones, Tommy Rampling, Katharina Kranzer, Stephen Morris-Jones, Sarah Logan, Gabriele Pollara  
    Clinical Infectious Diseases, ciz991, https://doi.org/10.1093/cid/ciz991, 11 October 2019  Abstract 

  • Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021  
    Gemma Hobson, James Adamson, Hugh Adler, Richard Firth, Susan Gould, Catherine Houlihan, Christopher Johnson, David Porter, Tommy Rampling, Libuse Ratcliffe, Katherine Russell, Ananda Giri Shankar, Tom Wingfield 
    Eurosurveillance, Volume 26, Issue 32, 12/Aug/2021  Abstract Paper